Skip Nav Destination
Issues
1 January 2020
-
Cover Image
Cover Image
ABOUT THE COVER
During the process of tumorigenesis, differentiated cells progressively acquire changes to their gene expression program that drive the cell toward a malignant, stem cell-like state. The precise mechanisms underlying these changes are poorly defined, though it can generally be said that de-differentiation primarily occurs through the loss or inactivation of cell lineage factors. In this issue, Lee and colleagues detail new insights into the molecular mechanisms regulating the differentiation states of colorectal cancer cells. They further suggest possible avenues to reprogram tumor cells into a nonmalignant post-mitotic state by overcoming the epigenetic barrier to the differentiated state, as depicted conceptually on the cover. For more information, see the Highlight on page 1 and the article on page 118. - PDF Icon PDF LinkTable of Contents
- PDF Icon PDF LinkEditorial Board
ISSN 1541-7786
EISSN 1557-3125
Molecular Cancer Research
Table of Contents
Highlights
Review
Minireview
Rapid Impact
Cancer Genes and Networks
A TFAP2C Gene Signature Is Predictive of Outcome in HER2-Positive Breast Cancer
Vincent T. Wu; Boris Kiriazov; Kelsey E. Koch; Vivian W. Gu; Anna C. Beck; Nicholas Borcherding; Tiandao Li; Peter Addo; Zachary J. Wehrspan; Weizhou Zhang; Terry A. Braun; Bartley J. Brown; Vimla Band; Hamid Band; Mikhail V. Kulak; Ronald J. Weigel
Cancer “-omics”
Cell Fate Decisions
Metabolism
New Horizons in Cancer Biology
Neoadjuvant Chemotherapy Shifts Breast Tumor Microbiota Populations to Regulate Drug Responsiveness and the Development of Metastasis
Akiko Chiba; Alaa Bawaneh; Christine Velazquez; Kenysha Y.J. Clear; Adam S. Wilson; Marissa Howard-McNatt; Edward A. Levine; Nicole Levi-Polyachenko; Shaina A. Yates-Alston; Stephen P. Diggle; David R. Soto-Pantoja; Katherine L. Cook
RNA Biology
Tumor Microenvironment and Immunobiology
Author Choice
PRMT6 Promotes Lung Tumor Progression via the Alternate Activation of Tumor-Associated Macrophages
Sreedevi Avasarala; Pei-Ying Wu; Samia Q. Khan; Su Yanlin; Michelle Van Scoyk; Jianqiang Bao; Alessandra Di Lorenzo; Odile David; Mark T. Bedford; Vineet Gupta; Robert A. Winn; Rama Kamesh Bikkavilli
Acknowledgment to Reviewers
Journal Archive
Molecular Cancer Research
(2002-Present; volumes 1-current)Published monthly since November, 2002.
(ISSN 0008-5472)
Cell Growth & Differentiation
(1990-2002; volumes 1-13)Published monthly 1990- September, 2002.
(ISSN 1044-9523)
Advertisement
Email alerts
NOTICE: This notice serves to inform the reader that, in 2023, AACR received a donation by Pfizer of the rights to royalties from the sale—within the United States—of Bavencio® (avelumab), a pharmaceutical owned by Merck. None of these funds are being, or will be, used to directly support any specific publication or author. If an individual article is published that deals with this particular drug, such article will include standard financial disclosures per AACR journal policy. For more detail regarding AACR’s established policies for authors, please go to https://aacrjournals.org/pages/editorial-policies#coi.